Koers Optigenex Inc. Other OTC
Aandelen
OPGX
US6838863032
Farmaceutische producten
Omzet 2006 | 301K 277K | Omzet 2007 | 466K 429K | Marktkapitalisatie | 44,73K 41,14K |
---|---|---|---|---|---|
Nettowinst (verlies) 2006 | -7 mln. -6,44 mln. | Nettowinst (verlies) 2007 | -2 mln. -1,84 mln. | EV/omzet 2006 | 20,5 x |
Nettoschuld 2006 | 6 mln. 5,52 mln. | Nettoschuld 2007 | 8,93 mln. 8,22 mln. | EV/omzet 2007 | 19,3 x |
K/w-verhouding 2006 * |
-
| K/w-verhouding 2007 |
-
| Werknemers | - |
Dividendrendement 2006 * |
-
| Dividendrendement 2007 |
-
| Vrij verhandelbaar | 21,27% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Daniel A. Zwiren
CEO | Chief Executive Officer | 67 | 13-05-06 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Daniel A. Zwiren
CEO | Chief Executive Officer | 67 | 13-05-06 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,01% | 709 mld. | |
+31,00% | 595 mld. | |
-2,60% | 367 mld. | |
+20,83% | 334 mld. | |
+5,69% | 289 mld. | |
+14,43% | 239 mld. | |
+9,24% | 211 mld. | |
-3,56% | 203 mld. | |
+10,77% | 171 mld. |